Skip to content

Clinical trials

Respiratory Insufficiency trials with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Respiratory Insufficiency Phase: Not applicable Clear all

651 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20022
20032
20043
20056
200610
20079
20089
200910
201020
201124
201220
201327
201424
201527
201634
201731
201844
201941
202053
202142
202238
202348
202450
202535
202636

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed317
Unknown status121
Recruiting77
Terminated57
Not yet recruiting35
Withdrawn21
Active, not recruiting16
Enrolling by invitation4
Suspended3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Massachusetts General Hospital11
Assistance Publique - Hôpitaux de Paris10
University of Sao Paulo General Hospital8
University Health Network, Toronto7
Universitätsklinikum Hamburg-Eppendorf7
Assiut University6
Fondazione Policlinico Universitario Agostino Gemelli IRCCS6
Laval University6
ResMed6
University Hospital, Bordeaux6

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Respiratory Insufficiency651
Pulmonary Disease, Chronic Obstructive43
Respiratory Distress Syndrome37
Hypoxia35
COVID-1932
Critical Illness29
Respiratory Aspiration27
Pneumonia19
Hypercapnia18
Dyspnea16

Trials

Showing 1 to 25 of 651. Each trial links to its page on Pharma Observatory.

551 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.